Laurie J. Hall Trustee’s United Therapeutics UTHR Stock Holding History

Laurie J. Hall Trustee’s Portfolio UTHR Stock Details UTHR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-150	Closed	-$12K	–	335
2019 Q2	$12K	Hold	150	–	–	0.01%	259
2019 Q1	$18K	Hold	150	–	–	0.01%	238
2018 Q4	$18K	Hold	150	–	–	0.01%	234
2018 Q3	$19K	Hold	150	–	–	0.01%	249
2018 Q2	$17K	Hold	150	–	–	0.01%	258
2018 Q1	$17K	Hold	150	–	–	0.01%	255
2017 Q4	$22K	Hold	150	–	–	0.01%	244
2017 Q3	$17.6K	Hold	150	–	–	0.01%	217
2017 Q2	$19.5K	Hold	150	–	–	0.01%	203
2017 Q1	$18.5K	Hold	150	–	–	0.01%	209
2016 Q4	$22K	Buy	+150	New	+$19.2K	0.01%	200
2016 Q2	$17K	Buy	150 +90	+150%	+$10K	0.01%	207
2016 Q1	$7K	Buy	+60	New	+$7.59K	﹤0.01%	222

Other funds holding UTHR

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

PAI

Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

CCM

Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Laurie J. Hall Trustee's UTHR Position: Q3 2019 in Review

Laurie J. Hall Trustee sold out of United Therapeutics (UTHR) in Q3 2019, closing a stake of 150 shares — an estimated $12K sold.

Laurie J. Hall Trustee first reported a position in UTHR in Q1 2016 and held it in 13 quarters. The position peaked at $22K in Q4 2017. 302 funds tracked by Wall St. Rank hold UTHR as of Q3 2019.

Laurie J. Hall Trustee reported no remaining United Therapeutics position as of Q3 2019 after selling out during the quarter.
Laurie J. Hall Trustee sold 150 United Therapeutics shares in Q3 2019, an estimated $12K.
Laurie J. Hall Trustee first reported a position in United Therapeutics in Q1 2016 and held it in 13 quarters.
Laurie J. Hall Trustee's United Therapeutics position peaked at $22K in Q4 2017.
302 funds tracked by Wall St. Rank held United Therapeutics as of Q3 2019.

Based on Laurie J. Hall Trustee's 13F filing for Q3 2019, filed 25 Oct 2019.